ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025
Exploiting a New Strategy to Prepare Water-Soluble Heteroleptic Iridium(III) Complexes to Control Electrochemiluminescence Reaction Pathways in Aqueous Solution.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanistic insights into electrochemiluminescence: fueling advances in bioanalysis and imaging.Chemical science · 2026Review
- Redox-mediator enhanced electrochemiluminescence under non-aqueous conditions.Chemical science · 2026Article
- Bright Circularly Polarized Electrochemiluminescence from Heterobinuclear IrAngewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The direct derivatization of heteroleptic iridium(III) complexes with sulfonate groups removes the limitations of prior strategies for the preparation of water-soluble analogues, in which complexes were prepared from a narrow range of ligands with suitably polar or charged functional groups. Phenylpyridine, phenylpyrazole, and phenylbenzothiazole ligands were selectively sulfonated opposite to their cyclometalated carbon within iridium(III) complexes containing bipyridine or N-heterocyclic carbene ancillary ligands. Altering reaction conditions enabled additional sulfonation of the benzothiazole fragments. Informed by the electrochemical and photophysical properties of the parent complexes in organic solvents, we adopted this strategy to design six novel luminophores that proceeded through three different sets of coreactant electrochemiluminescence (ECL) reaction pathways under aqueous conditions. The intensity of the indirect coreactant ECL of one of the iridium(III) luminophores was enhanced by over an order of magnitude by introducing a redox mediator, extending this promising analytical approach beyond the conventional [Ru(bpy)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.